New scan could spot pituitary tumors more clearly

NCT ID NCT07254104

ENROLLING_BY_INVITATION Diagnosis Sponsor: Peking Union Medical College Hospital Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early-phase study tests a new radioactive tracer called [68Ga]Ga-NOTA-RF for PET scans in 30 people with pituitary tumors. The goal is to see if this tracer can better highlight tumors and help doctors tell different tumor types apart. Participants receive an injection of the tracer and then undergo a PET scan. The study focuses on imaging accuracy, not treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: [68Ga]Ga-NOTA-RF (a radioactive tracer for PET scans)
What this could lead to: If successful, this could lead to more accurate imaging and classification of pituitary tumors, helping doctors choose better treatments.
What could go wrong: This is a very early, small study (30 people) focused on imaging, not treatment. The tracer may not prove useful in practice, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PITUITARY ADENOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

pituitary gland adenoma Pituitary Neoplasms pituitary tumor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PITUITARY NEOPLASMS

Contacts and locations

Locations

Peking Union Medical College Hospital

Beijing, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.